Comparative analytical costs of central laboratory glucose and bedside glucose testing: A College of American Pathologists Q-Probes study

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 7, 2004, Pages 739-745

  Howanitz, Peter J ^a   Jones, Bruce A ^b,c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; REAGENT;

ARTICLE; COMPARATIVE STUDY; COST; EQUIPMENT; GLUCOSE TOLERANCE TEST; LABORATORY; MONITORING;

BLOOD GLUCOSE; BLOOD SPECIMEN COLLECTION; HOSPITAL COSTS; HUMANS; LABORATORIES, HOSPITAL; POINT-OF-CARE SYSTEMS; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 3042794161     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Zaloga GP. Evaluation of bedside testing options for the critical care unit. Chest. 1990;97(suppl):185S-190S.
2. Hacckel R. Cost implications of decentralized testing: a laboratorian's view. In: Ashby J, ed. The Patient and Decentralized Testing. Lancaster, England: MTP Press; 1986:109-117.
3. Greendyke RM. Cost analysis: bedside blood glucose testing. Am J Clin Pathol. 1992;97:106-107.
4. Winkelman JW, Wybenga DR, Tanasijevic MJ. The fiscal consequences of central vs distributed testing of glucose. Clin Chem. 1994;40:1628-1630.
5. Cembrowski GS, Kiechle FL. Point of care testing: critical analysis and practical application. Adv Pathol Lab Med. 1994;7:3-24.
6. Nosanchuk JS, Keefner R. Cost analysis of point-of-care laboratory, testing in a community hospital. Am J Clin Pathol. 1995;103:240-243.
7. Lyons AW. The luxury of bedside testing. Am J Clin Pathol. 1995;104:107-108.
8. Lee-Lewandrowski E, Laposata M, Eschenbach K, et al. Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: implications for managing point of care testing. Am J Med. 1994;97:222-230.
9. De Cresce RP, Phillips DL, Howanitz PJ. Financial justification of alternate site testing. Arch Pathol Lab Med. 1995;119:898-901.
10. Howanitz PJ. Quality assurance measurements in departments of pathology and laboratory medicine. Arch Pathol Lab Med. 1990;114:1131-1135.
11. Ward-Cook K, Chapman S, Tannar S. 2002 wage and vacancy survey of medical laboratories. Lab Med. 2003;9:631-638.
12. Bachner P. Alternate site testing: the old and new paradigm or the past is prologue. Arch Pathol Lab Med. 1995;119:881-885.
13. Lamb LS. Responsibilities in point-of-care testing: an institutional perspective. Arch Pathol Lab Med. 1995;119:886-889.
14. Belanger AC. Alternate site testing: the regulatory perspective. Arch Pathol Lab Med. 1995;119:902-906.
15. Ford A. The sweet smell of safety. CAP Today. 2003;17(4):34-44.
16. Kost GJ. Preventing medical errors in point-of-care testing: security, validation, performance, safeguards, and connectivity. Arch Pathol Lab Med. 2001;125:1307-1315.
17. Kilgore ML, Steindel SJ, Smith JA. Estimating costs and turnaround times: presenting a user-friendly tool for analyzing costs and performance. Clin Lab Manage Rev. 1999;13:179-187.
18. Winkelman JW, Woo J, Tirabassi CP, O'Connell M. Centralization and decentralization of the hospital clinical laboratory. In: Vonderschmitt DJ, ed. Clinical Biochemistry Principles and Methods. Berlin, Germany: Walter de Gruyter; 1991:81-98.
19. Hernandez JS. Cost-effectiveness of laboratory testing. Arch Pathol Lab Med. 2003;127:440-445.